The historic rise of Viagra has firmly established as a example of pharmaceutical success, yet its position within the broader industry now raises questions about long-term returns . Generic versions are diminishing exclusivity , causing concerns that investing in companies heavily reliant to Viagra's former position could be a problematic strategy